Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)
CNY 25.86
(0.62%)
CNY 25.86
(0.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 267.81 Million CNY | 7.49% |
| 2022 | 249.14 Million CNY | -57.69% |
| 2021 | 588.82 Million CNY | 116.9% |
| 2020 | 271.47 Million CNY | 54.61% |
| 2019 | 175.58 Million CNY | 75.38% |
| 2018 | 100.11 Million CNY | 53.29% |
| 2017 | 65.31 Million CNY | 61.52% |
| 2016 | 40.43 Million CNY | 64.09% |
| 2015 | 24.64 Million CNY | -19.67% |
| 2014 | 30.67 Million CNY | 60.62% |
| 2013 | 19.09 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 239.67 Million CNY | -21.89% |
| 2024 Q2 | 306.84 Million CNY | -4.11% |
| 2024 Q1 | 320.01 Million CNY | 19.49% |
| 2023 Q3 | 234.78 Million CNY | 17.47% |
| 2023 Q4 | 267.81 Million CNY | 14.07% |
| 2023 FY | 267.81 Million CNY | 7.49% |
| 2023 Q1 | 230.17 Million CNY | -7.61% |
| 2023 Q2 | 199.86 Million CNY | -13.17% |
| 2022 Q2 | 297.71 Million CNY | -36.0% |
| 2022 Q1 | 465.18 Million CNY | -21.0% |
| 2022 FY | 249.14 Million CNY | -57.69% |
| 2022 Q4 | 249.14 Million CNY | 31.17% |
| 2022 Q3 | 189.94 Million CNY | -36.2% |
| 2021 Q4 | 588.82 Million CNY | -6.9% |
| 2021 FY | 588.82 Million CNY | 116.9% |
| 2021 Q2 | 530.17 Million CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 632.5 Million CNY | 19.3% |
| 2020 Q4 | 271.47 Million CNY | 4.86% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 271.47 Million CNY | 54.61% |
| 2020 Q2 | 204.88 Million CNY | 0.0% |
| 2020 Q3 | 258.88 Million CNY | 26.36% |
| 2019 Q4 | 175.58 Million CNY | 3.62% |
| 2019 FY | 175.58 Million CNY | 75.38% |
| 2019 Q3 | 169.45 Million CNY | 39.55% |
| 2019 Q2 | 121.42 Million CNY | 0.85% |
| 2019 Q1 | 120.41 Million CNY | 20.27% |
| 2018 Q3 | 98.24 Million CNY | 27.4% |
| 2018 Q4 | 100.11 Million CNY | 1.91% |
| 2018 FY | 100.11 Million CNY | 53.29% |
| 2018 Q1 | 67.32 Million CNY | 3.09% |
| 2018 Q2 | 77.11 Million CNY | 14.54% |
| 2017 Q4 | 65.31 Million CNY | 21.33% |
| 2017 Q3 | 53.83 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 65.31 Million CNY | 61.52% |
| 2016 Q2 | 30.37 Million CNY | 0.0% |
| 2016 Q4 | 40.43 Million CNY | 0.0% |
| 2016 Q3 | 40.43 Million CNY | 33.14% |
| 2016 Q1 | 30.37 Million CNY | 23.25% |
| 2016 FY | 40.43 Million CNY | 64.09% |
| 2015 Q3 | 24.64 Million CNY | 0.0% |
| 2015 Q4 | 24.64 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 24.64 Million CNY | -19.67% |
| 2014 FY | 30.67 Million CNY | 60.62% |
| 2013 FY | 19.09 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Guangxi Yuegui Guangye Holdings Co., Ltd. | 1.99 Billion CNY | 86.574% |
| Nanning Sugar Industry Co.,Ltd. | 4.49 Billion CNY | 94.047% |